Diabetes drug Avandia, has been associated with various diseases like heart attacks, heart failure, bone fractures, anemia and retinal edema with vision loss. As a result, the non-profit body called Public Citizen has filed a petition to the FDA to ban the drug. Avandia Plaintiffs Steering Committee has confirmed it.
An US team of researchers have identified that diabetes can work as a major reason of hearing loss. The study by the group of researchers have found out that adults with diabetes are about twice as likely to have impaired hearing. It can be added that hearing loss has so far been an unrecognised feature of diabetes.
Dr Kathleen Bainbridge, of the researcher group said, “We found that hearing loss was much more common in people with diabetes than people without the disease.”
AstraZeneca’s Oral Drug Onglyza (Saxagliptin) Successful in Type 2 Diabetes Control, May Be Available Soon
AstraZeneca, the second largest drug maker in UK is all set to launch its newest product Saxagliptin for late stage diabetes. The drug is to be released in the brand name of Onglyza. The drug which is to be released in Saturday claims to treat the late stage diabetes effectively. The new drug comes in the group of DPP-4 and is an oral one.